Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

Similar articles for PubMed (Select 15061198)

1.

Prognostic significance of surface markers expressed in multiple myeloma: CD56 and other antigens.

Sahara N, Takeshita A.

Leuk Lymphoma. 2004 Jan;45(1):61-5. Review.

PMID:
15061198
2.

Clinicopathological and prognostic characteristics of CD56-negative multiple myeloma.

Sahara N, Takeshita A, Shigeno K, Fujisawa S, Takeshita K, Naito K, Ihara M, Ono T, Tamashima S, Nara K, Ohnishi K, Ohno R.

Br J Haematol. 2002 Jun;117(4):882-5.

PMID:
12060125
4.

Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis.

Kremer M, Ott G, Nathrath M, Specht K, Stecker K, Alexiou C, Quintanilla-Martinez L, Fend F.

J Pathol. 2005 Jan;205(1):92-101.

PMID:
15586381
5.

Evaluation of serum neural cell adhesion molecule as a prognostic marker in multiple myeloma.

Poley S, Stieber P, Nüssler V, Pahl H, Fateh-Moghadam A.

Anticancer Res. 1997 Jul-Aug;17(4B):3021-4.

PMID:
9329591
6.

Soluble and membrane levels of molecules involved in the interaction between clonal plasma cells and the immunological microenvironment in multiple myeloma and their association with the characteristics of the disease.

Perez-Andres M, Almeida J, Martin-Ayuso M, De Las Heras N, Moro MJ, Martin-Nuñez G, Galende J, Cuello R, Abuín I, Moreno I, Domínguez M, Hernandez J, Mateo G, San Miguel JF, Orfao A.

Int J Cancer. 2009 Jan 15;124(2):367-75. doi: 10.1002/ijc.23941.

PMID:
19003959
7.

The neural cell adhesion molecule NCAM in multiple myeloma.

Kaiser U, Auerbach B, Oldenburg M.

Leuk Lymphoma. 1996 Feb;20(5-6):389-95. Review.

PMID:
8833394
8.

Utility of CD56 immunohistochemical studies in follow-up of plasma cell myeloma.

Harrington AM, Hari P, Kroft SH.

Am J Clin Pathol. 2009 Jul;132(1):60-6. doi: 10.1309/AJCPOP7TQ3VHHKPC.

9.

Soluble CD56 (NCAM): a new differential-diagnostic and prognostic marker in multiple myeloma.

Kaiser U, Oldenburg M, Jaques G, Auerbach B, Havemann K.

Ann Hematol. 1996 Sep;73(3):121-6.

PMID:
8841099
10.

Clinicopathological correlates of CD56 expression in multiple myeloma: a unique entity?

Mathew P, Ahmann GJ, Witzig TE, Roche PC, Kyle RA, Greipp PR.

Br J Haematol. 1995 Jun;90(2):459-61.

PMID:
7540857
12.

Immunohistochemical evaluation of 95 bone marrow reactive plasmacytoses.

Ioannou MG, Stathakis E, Lazaris AC, Papathomas T, Tsiambas E, Koukoulis GK.

Pathol Oncol Res. 2009 Mar;15(1):25-9. doi: 10.1007/s12253-008-9069-1. Epub 2008 Jun 14.

PMID:
18553158
13.

In vitro and in vivo activity of the maytansinoid immunoconjugate huN901-N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine against CD56+ multiple myeloma cells.

Tassone P, Gozzini A, Goldmacher V, Shammas MA, Whiteman KR, Carrasco DR, Li C, Allam CK, Venuta S, Anderson KC, Munshi NC.

Cancer Res. 2004 Jul 1;64(13):4629-36.

14.

Prognostic significance of plasma cell morphology in multiple myeloma.

Paule B, Quillard J, Bisson M, Kahn MF, Massias P.

Nouv Rev Fr Hematol. 1988;30(4):209-12.

PMID:
3194186
15.

Significance of cell adhesion molecules, CD56/NCAM in particular, in human tumor growth and spreading.

Zeromski J, Nyczak E, Dyszkiewicz W.

Folia Histochem Cytobiol. 2001;39 Suppl 2:36-7. Review.

PMID:
11820619
16.

Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14).

Hundemer M, Klein U, Hose D, Raab MS, Cremer FW, Jauch A, Benner A, Heiss C, Moos M, Ho AD, Goldschmidt H.

Bone Marrow Transplant. 2007 Dec;40(11):1033-7. Epub 2007 Sep 24.

PMID:
17891186
17.

[Expression of CD117 antigen on multiple myeloma and its significance].

Li J, Luo SK, Zhang GC, Hong WD, Tong XZ.

Ai Zheng. 2004 Aug;23(8):951-4. Chinese.

PMID:
15301722
18.

Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities.

Colomo L, Loong F, Rives S, Pittaluga S, Martínez A, López-Guillermo A, Ojanguren J, Romagosa V, Jaffe ES, Campo E.

Am J Surg Pathol. 2004 Jun;28(6):736-47.

PMID:
15166665
19.

Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles.

Vega F, Chang CC, Medeiros LJ, Udden MM, Cho-Vega JH, Lau CC, Finch CJ, Vilchez RA, McGregor D, Jorgensen JL.

Mod Pathol. 2005 Jun;18(6):806-15. Erratum in: Mod Pathol. 2005 Jun;18(6):873. Medeiros, Leonard J [corrected to Medeiros, L Jeffrey].

20.

Contribution of neural cell adhesion molecule (NCAM) to hemopoietic system in monkeys.

Kato J, Hisha H, Wang XL, Mizokami T, Okazaki S, Li Q, Song CY, Maki M, Hosaka N, Adachi Y, Inaba M, Ikehara S.

Ann Hematol. 2008 Oct;87(10):797-807. doi: 10.1007/s00277-008-0513-9. Epub 2008 Jun 25.

PMID:
18575864
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk